Home >
Medicine Info >
Melanocyl Solution
Loading interface...

Melanocyl Solution

Manufactured byFRANCO INDIAN PHARMACEUTICALS PVT LTD
ContainsMethoxsalen
Description
Melanocyl Solution is a topical solution that is used as a skin-sensitizing agent along with light therapy for the treatment of vitiligo, a skin condition characterized by loss of skin color in patches.
QUICK LINKS:
Side effectsConcernsUsageRelated products

Side effects

Major & minor side effects for Melanocyl Solution

  • Itching and skin rash
  • Darkening of skin
  • Blistering and peeling of skin
  • Blisters on the skin
  • Severe burns from over exposure to UVA or sunlight
  • Photosensitivity of skin

Uses of Melanocyl Solution

What is it prescribed for?

  • Vitiligo
Read More
Concerns

Commonly asked questions

  • How long does it take for this medicine to take effect?
    The amount of time required for this medicine to show its action is not clinically established.
  • How long do the effects of this medicine last?
    The amount of time for which this medicine remains active in the body is not clinically established.
  • Is it safe to consume alcohol while taking this medicine?
    Interaction with alcohol is unknown. It is advisable to consult your doctor before consumption.
  • Is this a habit forming medicine?
    No habit-forming tendencies were reported.
  • Can this medicine be taken during pregnancy?
    This medicine is not recommended for use in pregnant women unless absolutely necessary. All the risks and benefits should be discussed with the doctor before using this medicine.
  • Can this medicine be taken while breast-feeding?
    This medicine is not recommended for use in breastfeeding women unless absolutely necessary. All the risks and benefits should be discussed with the doctor before using this medicine.

Allergy

This medicine is not recommended for use in patients with a known allergy to methoxsalen, any psoralen compounds, or any other inactive ingredients present along with it.

Aphakia

This medicine is not recommended for use in patients suffering from aphakia (a condition of absence or not having eye lens) due to the increased risk of worsening of the patient's condition.

Melanoma

This medicine is not recommended for use in patients with a history of melanoma due to the increased risk of worsening of the patient's condition.

Squamous Cell Carcinoma

This medicine is not recommended for use in patients with invasive squamous cell carcinomas due to the increased risk of worsening of the patient's condition.
Warnings for special population

Pregnancy

This medicine is not recommended for use in pregnant women unless absolutely necessary. All the risks and benefits should be discussed with the doctor before using this medicine.

Breast-feeding

This medicine is not recommended for use in breastfeeding women unless absolutely necessary. All the risks and benefits should be discussed with the doctor before using this medicine.
General warnings

Aging of skin and skin burning

After receiving treatment with this medicine and ultra-violet light, further exposure to sunlight and/or ultraviolet radiation may result in premature aging of the skin as well as serious burns. Patients should take all precautionary measures, as advised by the doctor, including covering the skin, using a sun blocking agent, wearing sunglasses, etc. in case they need to go outdoors.

Carcinogenicity

The use of this medicine and ultraviolet radiation therapy significantly increases the risk of cancer. This risk is especially higher in patients with a previous history of cancer or radiation therapy. All the risks and benefits should be discussed with the doctor before using/receiving this medicine.

Use in children

This medicine is not recommended for use in patients less than 12 years of age. However, even for patients under the age of 18 years, it should be used only if the benefits significantly outweigh the risks and only under the supervision of a healthcare professional.

Missed Dose

Since this medicine is usually administered in the clinical/hospital setting, the likelihood of a missed dose is very low. However, since this medicine is usually given in multiple cycles, if you miss a scheduled dose of this medicine, call your doctor immediately for further instructions.

Overdose

Since this medicine is usually administered in the clinical/hospital setting, the likelihood of an overdose is very low. However, emergency medical treatment will be initiated by the doctor if an overdose is suspected.
All drugs interact differently for person to person. You should check all the possible interactions with your doctor before starting any medicine.
Interaction with Alcohol

Description

Interaction with alcohol is unknown. It is advisable to consult your doctor before consumption.

Instructions

Interaction with alcohol is unknown. It is advisable to consult your doctor before consumption.
Interaction with Medicine

Verteporfin

Aminolevulinic acid

Disease interactions

Disease

Information not available.
Food interactions
Information not available.
Lab interactions
Information not available.
This is not an exhaustive list of possible drug interactions. You should consult your doctor about all the possible interactions of the drugs you’re taking.
Use this medicine exactly as prescribed by your doctor. Follow all the instructions given on the label/package insert. Do not sunbathe for 24 hours before using/receiving this medicine and having the UVA light treatment. For 24 hours following the treatment, avoid exposure to sunlight or artificial UV rays (sunlamps or tanning beds). You are advised to take all precautionary measures such as wearing protective clothing, wearing sunblock, wearing sunglasses, etc. if you need to go outdoors within 24 hours of therapy.
Miscelleneous

Usage does not depend on food timings

To be taken as instructed by doctor

Does not cause sleepiness

How it works
This medicine acts upon the DNA of the skin cells to bring about its therapeutic effects. It also stimulates melanocytes (melanin forming skin cells) to move up the hair follicle and to repopulate the epidermis.
Legal Status

Approved

Unknown

Approved

Unknown

Classification

Category

Topical photochemotherapeutics

Schedule

Schedule H

Methoxsalen [Internet]. Pubchem.ncbi.nlm.nih.gov. 2020 [cited 20 June 2020]. Available from:

https://pubchem.ncbi.nlm.nih.gov/compound/Methoxsalen

Methoxsalen - DrugBank [Internet]. Drugbank.ca. 2020 [cited 20 June 2020]. Available from:

https://www.drugbank.ca/drugs/DB00553

PalsonsDerma :: [Internet]. Palsonsderma.com. 2020 [cited 26 June 2020]. Available from:

https://www.palsonsderma.com/octamop-tablets

Salen Topical Solution [Internet]. Nulifepharma.com. 2020 [cited 26 June 2020]. Available from:

http://www.nulifepharma.com/p-products/salen-capsules-solution

Methoxsalen Lotion (Topical) | NSC [Internet]. Nsc.com.sg. 2020 [cited 26 June 2020]. Available from:

https://www.nsc.com.sg/Patient-Guide/Health-Library/List-of-Dermatological-Drugs/Pages/Methoxsalen-Lotion-(Topical).aspx
Loading related questions...
Something doesn’t feel right?
Report an error

Information on this page was last updated on 26 Jun 2020

Disclaimer

We’ve made all possible efforts to ensure that the information provided here is accurate, up-to-date and complete, however, it should not be treated as a substitute for professional medical advice, diagnosis or treatment. Practo only provides reference source for common information on medicines and does not guarantee its accuracy or exhaustiveness. The absence of a warning for any drug or combination thereof, should not be assumed to indicate that the drug or combination is safe, effective, or appropriate for any given patient. Practo does not assume any responsibility for any aspect of healthcare administered with the aid of information provided above. If you have any doubts about your medication then we strongly recommend that you consult with your doctor, nurse or healthcare provider. See detailed T&C here.